Q5154 Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg

Short descriptor: Inj, omlyclo, 5 mg

✓ Active HCPCS Level II 2026
Open Q5154 in the app →

Look up Q5154 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5154 is the HCPCS Level II code for Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2025-10-01
2026 Maintenance
No change this year

References

Cite This Page

Reference Q5154 with the canonical source and edition:

Q5154 — Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5154

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5154

Related Codes in Section Q

← Q5153 Inj, aflibercept-yszy, 1 mg Q5155 → Inj, aflibercept-jbvf, 1 mg
Q5150 Inj, aflibercept-mrbb, 1 mg Q5151 Inj, eculizumab-aagh, 2 mg Q5152 Inj, eculizumab-aeeb, 2 mg Q5153 Inj, aflibercept-yszy, 1 mg Q5155 Inj, aflibercept-jbvf, 1 mg Q5156 Inj, tocilizumab-anoh, 1 mg Q5157 Inj, denosumab-bmwo, 1 mg Q5158 Inj, denosumab-bnht, 1 mg Q5159 Inj, denosumab-dssb, 1 mg Q5160 Inj, jobevne, 10 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial